Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
The study suggests the higher costs for obesity likely reflected less comprehensive insurance coverage for this indication. We definitely identified a cost barrier associated with prescriptions for obesity alone, Goss says
A comparison with Siglec-9
The phase 2 diabetes trial (published in The Lancet) used the same general titration framework but with more intensive metabolic monitoring
Beyond diabetes management, GLP-1 medications have shown significant success in addressing obesity and supporting healthy weight loss
Young et al., 1999)
With zero artificial flavors, colors, or preservatives, every batch is third-party tested to ensure purity and potency.
US$ 20.43
US$ 25.24
US$ 21.87
US$ 25.52
US$ 24.31
US$ 20.59
US$ 25.90
